search

Privia Health Group Inc (PRVA)

OverviewChartFinancialsStatisticsEarningsInsider transactionsETFsNews

News

Real-time news feed aggregating press releases, regulatory filings, and global media coverage for a single company, filterable by date range, relevance score, and sentiment classification. Each article is tagged with company-specific and overall market sentiment — allowing investors to separate fundamental catalysts from broader market noise and monitor how the narrative around a stock is evolving over time.

Relevance *
40
Privia Health Group, Inc. (PRVA) Stock forecasts
Sep 24, 2026

Privia Health Group, Inc. (PRVA) Stock forecasts

Argus has lowered its target price for Privia Health Group, Inc. (PRVA) to $18.00. The current stock price for PRVA is $19.71. Privia Health Group Inc. is described as a technology-driven, national physician-enablement company.
Company relevance
100.00%
Company sentiment
Somewhat-Bearish
Overall sentiment
Somewhat-Bearish
Privia Health Group (PRVA) Stock Looks Rich Against Current Earnings
Sep 19, 2026

Privia Health Group (PRVA) Stock Looks Rich Against Current Earnings

Privia Health Group (PRVA) stock closed at US$19.85, but its P/E ratio of 90.2x is significantly higher than the healthcare sector average of 24.0x, suggesting it is overvalued based on current earnings. Despite a 23.1% fall in share price over the past five years, the market is paying a rich premium for its current profits. Simply Wall St's analysis indicates that the stock is overvalued when compared to a tailored benchmark considering its growth profile, margins, size, and risk.
Company relevance
100.00%
Company sentiment
Somewhat-Bearish
Overall sentiment
Somewhat-Bearish